Originally Posted by
life on mars
Speaking on the Today Programme, BBC medical editor Fergus Walsh claimed that multiple senior sources inside AstraZeneca said that in future, the company was unlikely to forego the profits enjoyed by the likes of Pfizer (set to make billions from its $19.50 jab, compared to the $4 tag for AstraZeneca’s) now that the European Commission has smeared the vaccine with claims of blood clotting and low efficacy. Not to mention threatening export controls, and blaming AstraZeneca for their shortfall in vaccine